A total of 2 studies suggested no significant difference between CA 19-9 and CEA and revealed that the DOR of CA 19-9 was lower than that of CEA for the diagnosis of pancreatic cancer [30, 36]. Here, CEACAM5 is linked to familial pancreatic carcinoma.